MWNA
AVXL icon

Marshall Wace North America’s Anavex Life Sciences AVXL Stock Holding History

Marshall Wace North America’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-179,185
Closed -$2.68M – 1449
2021
Q1 		$2.68M Buy
+179,185
New +$1.96M 0.01% 734
2018
Q3 		– Sell
-12,050
Closed -$32K – 923
2018
Q2 		$32K Buy
+12,050
New +$33.7K ﹤0.01% 1339
2017
Q3 		– Sell
-35,141
Closed -$176K – 1250
2017
Q2 		$176K Buy
+35,141
New +$203K ﹤0.01% 1231

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace North America's AVXL Position: Q2 2021 in Review

Marshall Wace North America sold out of Anavex Life Sciences (AVXL) in Q2 2021, closing a stake of 179,185 shares — an estimated $2.68M sold.

Marshall Wace North America first reported a position in AVXL in Q2 2017 and held it in 3 quarters. The position peaked at $2.68M in Q1 2021. 127 funds tracked by Wall St. Rank hold AVXL as of Q2 2021.

  • Marshall Wace North America reported no remaining Anavex Life Sciences position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 179,185 Anavex Life Sciences shares in Q2 2021, an estimated $2.68M.
  • Marshall Wace North America first reported a position in Anavex Life Sciences in Q2 2017 and held it in 3 quarters.
  • Marshall Wace North America's Anavex Life Sciences position peaked at $2.68M in Q1 2021.
  • 127 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.